BC
NUVB.WS

Boxer Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Boxer Capital’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-266,666
Closed -$26.1K – 34
2024
Q3 		$26.1K Hold
266,666
– – ﹤0.01% 67
2024
Q2 		$42.7K Hold
266,666
– – ﹤0.01% 60
2024
Q1 		$80.7K Hold
266,666
– – ﹤0.01% 58
2023
Q4 		$16K Hold
266,666
– – ﹤0.01% 51
2023
Q3 		$26.7K Hold
266,666
– – ﹤0.01% 72
2023
Q2 		$44K Hold
266,666
– – ﹤0.01% 78
2023
Q1 		$32K Hold
266,666
– – ﹤0.01% 74
2022
Q4 		$38.5K Hold
266,666
– – ﹤0.01% 70
2022
Q3 		$45K Hold
266,666
– – ﹤0.01% 72
2022
Q2 		$75K Hold
266,666
– – ﹤0.01% 74
2022
Q1 		$203K Hold
266,666
– – 0.01% 72
2021
Q4 		$504K Hold
266,666
– – 0.02% 71
2021
Q3 		$683K Hold
266,666
– – 0.02% 87
2021
Q2 		$693K Hold
266,666
– – 0.02% 94
2021
Q1 		$712K Buy
+266,666
New +$771K 0.02% 84

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Boxer Capital's NUVB.WS Position: Q4 2024 in Review

Boxer Capital sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2024, closing a stake of 266,666 shares — an estimated $26.1K sold.

Boxer Capital first reported a position in NUVB.WS in Q1 2021 and held it in 15 quarters. The position peaked at $712K in Q1 2021. 23 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2024.

  • Boxer Capital reported no remaining Nuvation Bio Inc Warrants position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 266,666 Nuvation Bio Inc Warrants shares in Q4 2024, an estimated $26.1K.
  • Boxer Capital first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 15 quarters.
  • Boxer Capital's Nuvation Bio Inc Warrants position peaked at $712K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.